Insulin biosimilars Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

By Type (Rapid Acting biosimilars, Long Acting biosimilars, Premixed Acting biosimilars), By Disease Indication Type (Type I Diabetes, Type II Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End user (Hospitals, Ambulatory Surgical Centers, Others), By Region and Competition, 2019-2029F

Published	Pages	Publisher	Report code
Apr 2024	187	TechSci Research	ASDR-663292

Published: Apr 2024 - Pages : 187 - Publisher : TechSci Research - Report code : ASDR-663292

1. Pfizer Inc

2. Novartis AG

3. Boehringer Ingelheim GmbH

4. Merck KGaA

5. Sanofi S.A

6. Viatris Inc

7. NOVO Nordisk A/S

8. Intas Pharmaceuticals Ltd

9. Sandoz International GmbH

10. Fresenius Kabi AG

Insulin Market - Global Forecast 2024-2030

This report can be of interest as well:

Insulin Market - Global Forecast 2024-2030

Published: April, 2024 | Report code: ASDR-664096